As winter rolls in and pollution levels spike, our lungs bear the brunt of the seasonal assault. The air we breathe, filled with invisible yet potent enemies, wreaks havoc on our health. Beyond the discomfort of coughing and sneezing, this escalating crisis has sparked a significant shift in the pharmaceutical industry. The respiratory segment is witnessing unprecedented growth, a trend that reflects both a public health challenge and an industry opportunity. Let’s dive into how air pollution is fuelling this transformation and what it means for our collective future. Air Pollution: The Catalyst for Change It’s no secret that poor air quality has become a persistent menace. Post Diwali smog and chilly winter air combine to create a perfect storm, aggravating respiratory conditions across demographics. From children with wheezing and breathlessness to elderly patients grappling with asthma and chronic obstructive pulmonary disease (COPD), the impact is widespread and relentl...